Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Post by JohnnyUtah16on Mar 21, 2019 10:27am
72 Views
Post# 29516472

Knight Takes Legal Action

Knight Takes Legal ActionSucks its come to this but had to be done.

https://ca.finance.yahoo.com/news/knight-therapeutics-initiates-legal-action-120000862.html


Mounting an unnecessary and self-serving proxy fight against Knight is disappointing enough to our shareholders but filtering Medison’s already limited cash to Mr. Jakobsohn’s personal campaign is inexcusable. On behalf of all Knight shareholders, we will not allow Mr. Jakobsohn to use Medison’s limited cash to fund his campaign against Knight,” said Knight CEO Jonathan Ross Goodman. “If Mr. Jakobsohn is going to carry out an activist campaign to benefit himself personally, it is only fair that Mr. Jakobsohn pay personally. His ongoing actions continue to illustrate that his interests aren’t aligned with other Knight shareholders. Our Board and management will continue to fight for the rights of our shareholders. Knight shareholders should understand that every dollar that Medison spends on this campaign is a dollar that could otherwise increase Medison’s net profit and Knight’s participation therein.”
Bullboard Posts